Crane v. Monterey Mushroom, Inc.

910 F. Supp. 2d 1032, 27 Am. Disabilities Cas. (BNA) 180, 2012 WL 5835833, 2012 U.S. Dist. LEXIS 163824
District Court, E.D. Tennessee·Decided November 16, 2012·No. No. 3:10-CV-149·Published·Cited by 2 cases

Opinion

MEMORANDUM OPINION

LEON JORDAN, District Judge.

This civil action is before the court for consideration of the “Motion for Summary Judgment of Defendant Monterey Mushrooms, Inc.” [doc. 24]. Plaintiff has filed a response [docs. 36, 37], and defendant has submitted a reply [doc. 38]. Oral argument is unnecessary, and the motion is ripe for the court’s determination.

Plaintiff has brought suit pursuant to the Americans with Disabilities Act (“ADA”), 42 U.S.C. § 12101 et seq., and the Family and Medical Leave Act (“FMLA”), 29 U.S.C. § 2601 et seq., for alleged discrimination related to the termination of his employment with defendant. For the reasons that follow, defendant’s motion will be denied.

I.

Background

Defendant grows and ships fresh and processed mushrooms, and it has operating facilities in several states, including Tennessee. In 2004, defendant hired plaintiff as an Engineering Manager in the [1039] Technical Services division, which was responsible for engineering capital projects. Capital projects involved making improvements or alterations to company facilities using capital rather than operating expenses. The Director of Technical Services, Mike Salewske, was hired in 1983, and he was the person to whom plaintiff reported. The other employees in the division were Mike Egan, the Construction Project Manager, who was hired in 1993 and a carpenter who worked in California. Salewske was located in California while plaintiffs office was in Knoxville, Tennessee. Plaintiff testified that 70% of his job involved capital improvements and 30% involved operational improvements. The multiple performance evaluations he received during his employment showed him to be “good or above-average.” Salewske considered plaintiff to be a competent engineer who knew the equipment, packing lines, and controls.

In the spring of 2008, defendant began losing money and continued to do so for a number of months. Cost-cutting measures were implemented, which included Shah Kazemi (“Shah” or “Kazemi”), the President and CEO of Monterey Mushrooms, Inc., directing that each facility reduce its total head count, including salaried positions, by 10%. Kazemi met with Salewske in October of 2008 regarding capital projects for the coming fiscal year. According to Kazemi’s affidavit testimony, he informed Salewske that because capital dollars were so tight, new procedures for capital project approval would be implemented along with management to control costs. He informed Salewske that until procedures were in place, no capital improvements would be approved for fiscal year 2009.

Kazemi met with Ray Selle, the Chief Financial Officer, in October/November 2008 to discuss corporate positions for elimination. Selle prepared a spreadsheet that identified corporate-level positions for possible elimination by March 2009, which included plaintiffs and Mike Egan’s positions. Kazemi and Selle did not consult with Salewske regarding the positions to be eliminated. Salewske stated that he had no involvement in the decision to eliminate plaintiffs and Egan’s positions.

In December 2008, plaintiff learned he had a high PSA and that his doctor suspected he had prostate cancer, which would need to be confirmed by a biopsy. Plaintiff informed Salewske of the situation. Salewske has testified that he did not inform Kazemi, Selle or other management personnel about plaintiffs cancer concern at that time, and Kazemi testified that he did not discuss plaintiffs cancer with Salewske. Selle testified that he did not learn about plaintiffs cancer until he had been terminated. Kazemi testified that Salewske did not discuss the possibility of plaintiffs having cancer in December 2008 and that he first learned about the cancer when he was informed of the confirmed diagnosis in January 2009. Plaintiff has testified that Salewske informed Kazemi in December 2008 and that he was angry and upset about his needing to be out of work. He also testified that he received the same response through Salewske after he had received his diagnosis. Plaintiffs diagnosis of prostate cancer was confirmed on January 13, 2009. Plaintiff informed Salewske of the diagnosis, and Salewske in turn notified Kazemi via email on January 14, 2009. Other management people also became aware of plaintiffs condition.

Kazemi testified that in December 2008 he reviewed the 2008 financials which showed increasing sales deficits. It was at that time Kazemi says he finalized the earlier decision to eliminate the positions held by plaintiff and Egan. However, he testified that he wanted to wait until after the holidays before he had Salewske notify [1040] plaintiff and Egan of the decision. On February 2, 2009, Kazemi informed Salewske that plaintiff and Egan would be laid off. The next day, Salewske called plaintiff and told him he was laid off effective March 1, 2009. Shortly after, Salewske informed Egan that he too was laid off effective March 1, 2009. On February 4, 2009, Plaintiff requested information regarding FMLA from the human resources (“HR”) department, and he applied for FMLA on February 5, 2009. Sylvia Ayala, the Corporate HR Manager, completed plaintiffs termination form on February 4, 2009.

In support of his FMLA claim, plaintiff had his treating physician, Dr. McDonald, submit a “Certification of Health Care Provider.” Dr. McDonald stated that plaintiff would receive treatment beginning February 27, 2009, and his recovery time would be approximately two weeks. The doctor estimated that plaintiffs period of incapacity would be from February 27, 2009 through March 12, 2009.

After plaintiffs position was eliminated, Salewske took over plaintiffs projects and absorbed some of his job duties. The record also reflects that no one has been hired to replace the plaintiff.

II.

Standard of Review

Free access — add to your briefcase to read the full text and ask questions with AI

Crane v. Monterey Mushroom, Inc., 910 F. Supp. 2d 1032, 27 Am. Disabilities Cas. (BNA) 180, 2012 WL 5835833, 2012 U.S. Dist. LEXIS 163824 (E.D. Tenn. 2012).

910 F. Supp. 2d 1032 (Crane v. Monterey Mushroom, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related